About FDA
Number of highest risk products domestic inspections completed in a month
Cumulative FY 2012 Performance Goal Target: 11,302
Dictionary: A high risk firm is a firm that is producing a food product that may present a high potential for harm if consumed when the food has been prepared under inadequate conditions such as improper processing, storage, handing and distribution.. From this high-risk list, ORA creates a workplan of high-risk inspections to complete for the year.
Fiscal Year - 2012
Cumulative FY 2012 Performance Goal Target: 11,302
| Time | Monthly Guideline to Reach Cumulative FY 2012 Performance Goal Target | Number |
|---|---|---|
| Oct 2011 | 752 | 1,071 |
| Nov 2011 | 752 | 1,265 |
| Dec 2011 | 755 | 1,322 |
| Jan 2012 | 1,128 | 1,194 |
| Feb 2012 | 1,130 | 1,235 |
| Mar 2012 | 1,132 | 1,516 |
| Apr 2012 | 1,036 | 1,059 |
| May 2012 | 1,038 | 1,177 |
| Jun 2012 | 1,041 | 1,190 |
| Jul 2012 | 844 | 915 |
| Aug 2012 | 845 | 1,064 |
| Sep 2012 | 848 | 832 |
FY 2012 Total: 13,840
Cumulative annual highest risk product domestic inspections completed by the end of the month
Cumulative FY 2012 Performance Goal Target: 11,302
Fiscal Year - 2012
Cumulative FY 2012 Performance Goal Target: 11,302
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 1,071 |
| Nov 2011 | N/A | 2,336 |
| Dec 2011 | N/A | 3,658 |
| Jan 2012 | N/A | 4,852 |
| Feb 2012 | N/A | 6,087 |
| Mar 2012 | N/A | 7,603 |
| Apr 2012 | N/A | 8,662 |
| May 2012 | N/A | 9,839 |
| Jun 2012 | N/A | 11,029 |
| Jul 2012 | N/A | 11,994 |
| Aug 2012 | N/A | 13,008 |
| Sep 2012 | N/A | 13,840 |
Cumulative percent of annual highest risk product domestic inspections completed at the end of the month
Fiscal Year - 2012
| Time | Target | Cumulative Percent |
|---|---|---|
| Oct 2011 | N/A | 9 |
| Nov 2011 | N/A | 21 |
| Dec 2011 | N/A | 32 |
| Jan 2012 | N/A | 43 |
| Feb 2012 | N/A | 54 |
| Mar 2012 | N/A | 67 |
| Apr 2012 | N/A | 77 |
| May 2012 | N/A | 87 |
| Jun 2012 | N/A | 98 |
| Jul 2012 | N/A | 106 |
| Aug 2012 | N/A | 115 |
| Sep 2012 | N/A | 122 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
